Skip to main content

Table 7 Perinatal and neonatal mortality, and morbidity during the first month of life by treatment (%)

From: Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

  AL ASAQ MQAS DHAPQ p-valuea
N Valueb N Valueb N Valueb N Valueb
Perinatal mortality 837 15 (17.9) 789 14 (17.7) 787 22 (28.0) 784 19 (24.2) 0.77
Neonatal mortality 822 16 (19.5) 775 20 (25.8) 765 10 (13.1) 765 24 (31.4) 0.21
Morbidity          
 Fever (4–6 week) 764 37 (48.4) 718 34 (47.4) 715 42 (58.7) 680 23 (33.8) 0.82
 Diarrhoea (4–6 week) 764 14 (18.3) 717 22 (30.7) 715 19 (26.6) 679 4 (5.9) 0.62
 Cough (4–6 week) 764 34 (44.5) 717 33 (46.0) 715 56 (78.3) 679 52 (76.6) 0.02
 Difficulty in feeding (4–6 week) 764 2 (2.6) 717 5 (7.0) 715 6 (8.4) 679 1 (1.5) 0.76
 Jaundice (4–6 weeks) 764 0 (0.0) 717 1 (1.4) 714 2 (2.8) 679 1 (1.5) 0.90
 Other symptoms (4–6 week) 764 33 (43.2) 717 44 (61.4) 715 51 (71.3) 679 16 (23.6) 0.33
  1. ap-values are from logistic regression adjusted for country
  2. bvalues are n (/1000 live births) except perinatal mortality which has n (/1000 total births)